Scenic is unlocking the ground-breaking science of genetic modifiers to develop breakthrough therapies - we call this approach - Evolution Inspired Medicine.

Scenic is seeking strategic opportunities to partner and collaborate with pharma and biotech companies to explore the versatility of our Cell-Seq proprietary platform and discover and develop therapeutics that target genetic modifiers.

In September 2020, Scenic engaged in a multi-year strategic collaboration in target discovery and therapeutic development utilising Scenic’s Cell-Seq platform and its proprietary data warehouse

Netherland Cancer Institute
Scenic has collaborations with research groups at the Netherlands Cancer Institute and is open to collaborating with other renowned research institutions and universities.